Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mark Fendrick

Showing results (11-20 of 378) with videos related to

Pageof 38
Sort By:
American Journal of Therapeutics|May 21, 2003
Viral respiratory infections due to rhinoviruses: current knowledge, new developmentsA Mark Fendrick
The American Journal of Managed Care|December 30, 2004
COX-2 inhibitor use after Vioxx: careful balance or end of the rope?A Mark Fendrick
JAMA Network Open|July 25, 2020
The Need to Expand Coverage and Enhance Access to Essential Services on a Predeductible Basis Following COVID-19A Mark Fendrick
Journal of Managed Care & Specialty Pharmacy|August 29, 2019
Letter--Assessing the Effectiveness of V-BID ImplementationsBeth Shrosbree, A Mark Fendrick
The American Journal of Managed Care|May 15, 2003
Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experienceDarren Kocs, A Mark Fendrick
Cleveland Clinic Journal of Medicine|June 4, 2005
How to test for Helicobacter pylori in 2005Nimish Vakil, A Mark Fendrick
The American Journal of Managed Care|May 22, 2020
Expanding coverage for essential care during COVID-19A Mark Fendrick, Beth Shrosbree
The American Journal of Managed Care|July 19, 2018
Insights on site-of-care cancer research: both quality and cost information are necessary to guide policyKavita Patel, A Mark Fendrick
The American Journal of Managed Care|December 21, 2017
Expanding the "safe harbor" in high-deductible health plans: better coverage and lower healthcare costsA Mark Fendrick, Rashna Soonavala
The American Journal of Managed Care|November 14, 2022
Opportunity after crisis: enhancing value in the COVID-19 reboundDouglas Barthold, A Mark Fendrick
Pageof 38

Showing results (11-20 of 378) with videos related to

Sort By:
Pageof 38
American Journal of Therapeutics|May 21, 2003
Viral respiratory infections due to rhinoviruses: current knowledge, new developmentsA Mark Fendrick
The American Journal of Managed Care|December 30, 2004
COX-2 inhibitor use after Vioxx: careful balance or end of the rope?A Mark Fendrick
JAMA Network Open|July 25, 2020
The Need to Expand Coverage and Enhance Access to Essential Services on a Predeductible Basis Following COVID-19A Mark Fendrick
Journal of Managed Care & Specialty Pharmacy|August 29, 2019
Letter--Assessing the Effectiveness of V-BID ImplementationsBeth Shrosbree, A Mark Fendrick
The American Journal of Managed Care|May 15, 2003
Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experienceDarren Kocs, A Mark Fendrick
Cleveland Clinic Journal of Medicine|June 4, 2005
How to test for Helicobacter pylori in 2005Nimish Vakil, A Mark Fendrick
The American Journal of Managed Care|May 22, 2020
Expanding coverage for essential care during COVID-19A Mark Fendrick, Beth Shrosbree
The American Journal of Managed Care|July 19, 2018
Insights on site-of-care cancer research: both quality and cost information are necessary to guide policyKavita Patel, A Mark Fendrick
The American Journal of Managed Care|December 21, 2017
Expanding the "safe harbor" in high-deductible health plans: better coverage and lower healthcare costsA Mark Fendrick, Rashna Soonavala
The American Journal of Managed Care|November 14, 2022
Opportunity after crisis: enhancing value in the COVID-19 reboundDouglas Barthold, A Mark Fendrick
Pageof 38